Prado Carla Smith de Vasconcellos Crippa sold $188k of ABEV
See Remarks at AMBEV S.A.. 60,757 shares at an average of $3.09, traded Sep 3, 2026, filed Oct 8, 2026.
Score components
- +15RoleOfficer
- +12Trade size$188k at market
- +10Share of holdings soldSold 43% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-418085, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | SOpen-market sale Common Shares | -60,757 | $3.09 | $188k | 80,707 | 6 d ago |
Related signals
Other insiders at AMBEV S.A. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 45Moderate | ABEVsell AMBEV S.A. | Ricardo Manuel Frangatos Pires Moreira director | $1.4M 468,040 shares | -13% | |
| 42Moderate | ABEVsell AMBEV S.A. | Paulo Andre Zagman See Remarks | $465k 136,250 shares | -37% | |
| 50Moderate | AMBEV S.A. | de Lacerda Eduardo Braga Cavalcanti See Remarks | $434k 152,386 shares | -41% | |
| 40Moderate | AMBEV S.A. | Parente Guilherme Malik See Remarks | $58k 20,971 shares | -44% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.